Search clinical trials for: S-1, Gemcitabine, Cisplatin

Total 1613 results

Changzhou Cancer Hospital of Soochow University

Completed

An Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer (EASE)

Non-small Cell Lung Cancer

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Study to Evaluate the Safety and Efficacy of SHR-1210, Gemcitabine and Cis-platinum by R/M NPC Subjects

Nasopharyngeal Carcinoma

China
Yonsei University

Recruiting

Preoperative Chemoradiotherapy for Locally Advanced Resectable Gastric Adenocarcinoma

Gastric Adenocarcinoma

Korea, Republic of
Brown University
Cures Within Reach; Lifespan; Legorreta Cancer Center at Brown University

Recruiting

Targeting Androgen Signaling in Urothelial Cell Carcinoma - Neoadjuvant (TASUC-Neo)

Urothelial Carcinoma Bladder | Androgen Receptor Positive

United States
Kansai Hepatobiliary Oncology Group

Completed

Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer

Biliary Tract Cancer

Japan
Sun Yat-sen University

Completed

Moderately Hypofractionated Conformal Radiation Combined With S-1 for Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
Chinese PLA General Hospital

Recruiting

Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer

Pancreatic Neoplasms | Pancreatic Cancer | Pancreas Cancer | PDAC - Pancreatic Ductal Adenocarcinoma

China
Sanofi

Completed

ADVANCED Phase II Trial of Weekly vs 3 Weekly Docetaxel and Cisplatin Followed by Gemcitabine in Non-small-cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

Italy
Gilead Sciences

Terminated

Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Anti-Cancer Agents in Japanese Participants With Gastric or Gastroesophageal Junction Adenocarcinoma

Gastric Adenocarcinoma

Japan
Andrew Ko
Eli Lilly and Company; Taiho Pharmaceutical Co., Ltd.

Terminated

Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Pancreatic Cancer

United States
Insel Gruppe AG, University Hospital Bern
Swiss National Science Foundation; University of Bern

Recruiting

Magrolimab in Combination With Cytotoxic Chemotherapy in Advanced Urothelial Carcinoma (MACOCUC-01)

Advanced Urothelial Carcinoma

Switzerland
Japan Clinical Cancer Research Organization
Korean Cancer Study Group

Completed

Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer

Gastric Cancer

Japan
EpicentRx, Inc.

Terminated

RRx-001 in Second Line Treatment of Advanced Cholangiocarcinoma Prior to Readministration of First-Line Therapy (EPIC)

Cholangiocarcinoma

United States
Yonsei University

Completed

A Trial of Induction Chemotherapy and Chemoradiotherapy With TS-1 and Cisplatin (SP) as First-line Treatment in Patients With High Risk Advanced Gastric Cancer

Gastric Cancer

Korea, Republic of
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Wei Jiang
Wuzhou Red Cross Hospital; Guangxi Nanxishan Hospital; Laibin People's Hospital; Lingshan people's Hospital

Recruiting

Camrelizumab for the Treatment of Locally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Beijing Tiantan Hospital

Completed

EEG Characteristics of Different Sedation Depths in Neurosurgery Patients

Electroencephalography

China
IRCCS San Raffaele

Completed

A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma (PACT-19)

Pancreatic Cancer

Italy
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Taiho Oncology, Inc.
Quintiles, Inc.; United BioSource, LLC

Completed

Phase 2 Study of S-1 in Combination With Cisplatin as 1st Line Therapy in Advanced Non-Small Cell Lung Cancer

Advanced Non-Small Cell Lung Cancer
Fudan University

Recruiting

Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Carboplatin in Triple Negative Breast Cancer (TNBC) (TNBC)

Breast Cancer

China
Zhejiang Cancer Hospital

Completed

S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer

Esophageal Cancer | Chemoradiation

China
Zhu Xu

Unknown

A RCT of Oral S-1 in Combination With Sequential HAIC of Oxaliplatin After TACE in Patients With Advanced HCC (SOON)

Hepatocellular Carcinoma

China
European Organisation for Research and Treatment...

Completed

Pembrolizumab in Biliary Tract Cancer

Metastatic Cancer | Advanced Cancer | Biliary Tract Cancer | Gallbladder Cancer

United Kingdom, Spain, Germany
AstraZeneca

Active, not recruiting

Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON). (POSEIDON)

Non Small Cell Lung Cancer NSCLC

Poland, United States, Taiwan, Thailand, Vietnam, Korea, Republic of, United Kingdom, Brazil, Hungary, Japan, Mexico, Peru, Russian Federation, China, Germany, South Africa, Ukraine, Bulgaria, Hong Kong
Duke University
Eli Lilly and Company

Terminated

Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung Cancer (TOP0602)

Non Small Cell Lung Cancer

United States
Sun Yat-sen University

Completed

Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

China
Professor Fernando Figueira Integral Medicine Institute
Instituto Nacional de Cancer, Brazil

Completed

Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer Patients

Cancer of Cervix

Brazil
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
NCIC Clinical Trials Group

Completed

Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor

Head and Neck Cancer

Canada
Fudan University

Unknown

Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver Metastasis

Carcinoma, Pancreatic

China
Sun Yat-sen University

Unknown

Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC (NPC)

Nasopharyngeal Carcinoma

China
Air Force Military Medical University, China

Recruiting

GNT Induction Treatment in Locally Advanced NPC

Nasopharyngeal Carcinoma

China
University of Zurich

Completed

Neoadjuvant Chemotherapy for Resectable Cancer of the Pancreatic Head

Cancer of the Pancreatic Head

Switzerland
Jiangxi Provincial Cancer Hospital

Recruiting

Adding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPC

Nasopharyngeal Carcinoma

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer (IFCSLAPC)

Pancreatic Cancer

China
The First Affiliated Hospital with Nanjing Medical...

Unknown

Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer

Recurrence | Bladder Cancer | Prognosis | Gemcitabine and Cisplatin Chemotherapy | Epirubicin Instillation

China
Seoul National University Hospital

Completed

Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic Cancer

Pancreatic Cancer

Korea, Republic of
National University Hospital, Singapore

Recruiting

Cisplatin Combined With Oral TS-1 in Patients With Advanced Solid Tumors With Different Degrees of Liver Dysfunction

Cancer | Liver Dysfunction

Singapore
National University Hospital, Singapore
Yonsei University; National Cancer Centre, Singapore

Unknown

A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients (3G)

Recurrent Gastric Cancer

Singapore
IRCCS San Raffaele

Terminated

Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer (PACT-17)

Pancreatic Cancer

Italy
Spanish Lung Cancer Group

Completed

Randomized Customized Adjuvant Chemotherapy (GECP-SCAT) (GECP-SCAT)

Non-small-cell Lung Cancer

Spain
National Taiwan University Hospital

Completed

Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

Taiwan
Istituti Tumori Giovanni Paolo II
Gruppo Oncologico Italiano di Ricerca Clinica; Gruppo Oncologico Italia Meridionale and other collaborators

Unknown

Gemcitabine or Gemcitabine and Cisplatin in the Treatment of Advanced Pancreatic Cancer (GIP-1)

Pancreatic Cancer

Italy
European Lung Cancer Working Party

Completed

Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Belgium, France, Greece, Spain
Shanghai Zhongshan Hospital

Not yet recruiting

Combining Chemoradiotherapy With Sintilimab in First-Line ICC

ICC

China
Taiho Oncology, Inc.

Active, not recruiting

Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements (FOENIX-CCA3)

Advanced Cholangiocarcinoma | FGFR2 Gene Rearrangements

United States, Spain, United Kingdom, Australia, Taiwan, Italy, France, Korea, Republic of, Belgium, Japan, Thailand, Germany, Brazil, Peru, Portugal, Argentina, Hong Kong, Mexico, Netherlands, Poland
Changhai Hospital

Recruiting

Borderline Resectable Pancreatic Cancer Neoadjuvant Chemoradiotherapy Clinicaltrial-1 (BRPCNCC-1)

Pancreatic Cancer

China
GlaxoSmithKline

Completed

Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age

Malaria

Ghana, Kenya
EMD Serono

Terminated

Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States, Germany

3

Subscribe